Scientists have come up with a strategy that could prevent breast cancer from returning in another part of a patient’s body years or decades later.
In what experts have described as a “time bomb”, patients with the most common type of breast cancer – oestrogen receptor positive (ER+) – have a continued risk of their cancer recurring and forming incurable tumours, as secondary or metastatic breast cancer.
